BioSpace News Archive

Coherent Market Insights, a market intelligence and consulting company, has developed PHASE-XS, a sophisticated, easy to access database for companies interested in regulatory marketing approval, commercialization, and future improvements in biologics and biosimilars.

The Actuarial Foundation is proud to announce the finalists in the 2019 Modeling the Future Challenge, a national scholarship competition aimed at introducing the actuarial profession to high school students.

FDA orders boxed warning on packaging after studies confirm death risks

Kerecis, the company pioneering the use of fish skin in tissue regeneration, announced that the President of Iceland, HE Gudni Johannesson, has awarded the company’s Aurora Award to nurse Lisa Anne Jeffers and Dr. Bryan Folkers.

This Tecentriq combination is the first cancer immunotherapy regimen approved for breast cancer

Registered nurses overwhelmingly voted to authorize a strike affecting more than 10,000 registered nurses in New York City at three hospital systems: Mt. Sinai, Presbyterian and Montefiore.

AngioDynamics, Inc. announced that the United States District Court for the District of Delaware, on day four of a jury trial at the close of C.R. Bard’s case, granted judgement as a matter of law under rule 50 in favor of AngioDynamics, dismissing Bard’s suit alleging that certain of AngioDynamics’ implantable port products infringed three Bard patents.

Palo Alto Health Sciences, Inc. announced that it has received full accreditation from the Healthcare Quality Association on Accreditation as a durable medical equipment, prosthetics, orthotics and supplies provider.

Le Bonheur Children’s Hospital announced that Michael Wiggins, MBA, FACHE, will become its next president.

Experts from the ProfNet network who are available to discuss timely issues in your coverage area.